The Patent Finder

Lytix Biopharma

Also on record
Records under this name other than patents Lytix Biopharma holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.

Showing 1 to 4 of 4 · Back to Lytix Biopharma

Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
PatentTitleStatus Expires Confidence
US 7,439,228Bioactive Peptides
Lapsed on the fee record
Ended Oct 21, 2020 · High confidence
Lapsed on the fee recordEnded Oct 21, 2020High confidence
US 7,232,803Antimicrobial compounds and formulations
Formerly held
Lapsed on the fee record
Ended Jun 19, 2019 · USPTO record
Lapsed on the fee recordEnded Jun 19, 2019USPTO record
US 6,890,902Cytotoxic Modified Lactoferrin Peptides
Lapsed on the fee record
Ended May 10, 2017 · High confidence
Lapsed on the fee recordEnded May 10, 2017High confidence
US 7,393,824Methods of peptide preparation
Lapsed on the fee record
Ended Jul 1, 2016 · USPTO record
Lapsed on the fee recordEnded Jul 1, 2016USPTO record
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 21, 2026 · includes USPTO assignment data published Nov 20, 2026, status data published Nov 21, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited